KALRN and early-onset autosomal dominant Alzheimer disease: Previous studies have established a connection between kalirin variants and susceptibility to schizophrenia, Alzheimer disease, adult attention deficit hyperactivity disorder (ADHD), coronary artery disease and ischemic stroke [29-34].